Drug Type Small molecule drug |
Synonyms Tovedeso |
Target |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date DE (04 Jul 2017), |
Regulation- |
Molecular FormulaC26H37NO6 |
InChIKeyFRPJDSBXTGYKRS-VEIFNGETSA-N |
CAS Registry1512864-59-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Desfesoterodine Succinate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Urinary Bladder, Overactive | DE | 04 Jul 2017 |